Plain English Summary
Background and study aims
As the population ages, the pressure on hospital eye services is increasing. As a result, optometry-based enhanced eye care services are being developed to manage certain patient groups within the community. As their role widens, optometrists (eye doctors) spend more time on the investigation and management of eye diseases using a range of medical devices, with the measurement of the patient’s glasses prescription forming an ever smaller proportion of the eye examination. This means that patients often have to change seats many times so that the different devices can be used, which requires space in the optometric clinics and a longer time for standard eye examinations. This study is going to investigate whether a novel device to measure a patient’s glasses prescription, can help to save time and space in optometric clinics, while still accurately determining the glasses prescriptions. The device combines two currently used devices that measure and refine the glasses prescription, reducing the number of times the patient has to change seats during an eye examination. The aim of this study is to find out whether the novel device is an effective way of saving time and space in an optometric clinic whilst providing accurate results.
Who can participate?
Registered, returning customers aged between 13 and 45 attending the participating optometry practice for a routine eye examination that have good vision in both eyes.
What does the study involve?
All participants undergo their normal eye examination as planned. This involves measuring the time taken to assess their glasses prescription, including the time taken to move between seats placed at the different measuring devices used in the examination. Following this, participants have their prescription measured again using the novel device. The prescriptions measured using the novel device and the conventional techniques are compared, along with the time taken to determine the spectacle prescription in each case.
What are the possible benefits and risks of participating?
There are no specific benefits to participants taking part in the study. Participants will not receive payment and will have to pay for their eye examination as normal if they are a private patient. There are no known risks to being involved in the study, other than a small risk of feeling tired during the testing, but participants will be offered the opportunity for a break to minimise this risk. If a patient needs glasses, the results from the novel device being tested will not be used to determine the strength of any glasses prescribed.
Where is the study run from?
A community optometry practice located in Sale, Cheshire (UK)
When is the study starting and how long is it expected to run for?
May 2016 to September 2016
Who is funding the study?
Topcon Eye Care Company (Japan)
Who is the main contact?
Dr Catharine Chisholm
Catharine.chisholm@topcon.co.uk
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
T_SS_BEC_2016ct001
Study information
Scientific title
Comparison of the accuracy and duration of refractive error measurements determined using a novel, semi-automated measuring device versus conventional refraction techniques, in a normal optometric population
Acronym
Study hypothesis
The prototype device improves workflow in terms of time, space saving and patient journey, while maintaining accuracy in the measurement of refractive error, compared to the conventional methods of measuring refractive error.
Ethics approval
Not provided at time of registration
Study design
Single-centre non-randomised pilot study
Primary study design
Interventional
Secondary study design
Non randomised study
Trial setting
Other
Trial type
Other
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet.
Condition
Refractive error
Intervention
Participants will have their refractive error measured as part of their standard eye examination (auto-refractor and subjective refinement using a phoropter and letter chart), during which the time taken to determine their prescription will be measured.
Participants will then have their refractive error measured using the prototype device. The measurement and the time taken to determine the measurement, will be compared with the refractive result determined during the standard eye examination using conventional methods.
Intervention type
Device
Phase
Drug names
Primary outcome measures
1. Time taken to measure refractive error, including movement of participant between devices during the eye examination is measured using a stopwatch
2. Refractive outcome (sphere and cylinder) measured during the eye examination using conventional methods and with the prototype device (undertaken after the eye examination)
3. Number of times a participant must change seats is measured at the end of assessing each participant
Secondary outcome measures
1. Ease of use is rated by investigator using a questionnaire designed for the purpose of this study at the end of assessing each participant
2. Space taken up by prototype device versus conventional devices is assessed once at the start of the trial
Overall trial start date
09/05/2016
Overall trial end date
30/09/2016
Reason abandoned
Eligibility
Participant inclusion criteria
1. Registered, returning customers attending the optometry practice for a routine, full NHS or private eye examination, during the trial period
2. Aged betwen 13 and 45 years
3. Visual acuity (VA) in each eye better than 0.1 logarithm of the minimum angle of resolution (6/7.5) as determined from their previous records or during the eye examination
Participant type
Healthy volunteer
Age group
Mixed
Gender
Both
Target number of participants
50
Participant exclusion criteria
1. New customers attending the optometry practice for the first time
2. Patients attending for any other kind of optometric appointment other than a full eye examination
3. Those requiring significant adaptions to the standard subjective refraction process used in the eye examination, due to mental capacity/language. This includes the need to measure vision with picture or symbol charts rather than a letter chart
4. Individuals who do not exhibit normal binocular vision (ability for the two eyes to work together), including:
4.1. Subjects who report double vision as a symptom during the eye examination
4.2. Subjects who are found to have unstable binocular vision during the eye examination requiring the prescribing of exercises or prisms
4.3. Individuals with a history of lazy eye (amblyopia), suppression of vision in one eye and/or squint (turn in the eye) as recorded in their previous clinical records, or identified during the eye examination
5. Individuals with any ocular pathology or history of ocular surgery, including conditions known to affect the accuracy refraction measurements (media opacities)
6. Vulnerable subjects – will not be recruited on the basis that they would normally undergo a modified rather than the eye examination, adapted to meet their needs
Recruitment start date
02/08/2016
Recruitment end date
31/08/2016
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Community optometric practice
Sale
-
United Kingdom
Funders
Funder type
Industry
Funder name
Topcon Eye Care Company
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
No specific publication plans as this is a phase 1 trial of a prototype device and therefore the results will be used internally to guide further development work.
Intention to publish date
Participant level data
Not expected to be available
Results - basic reporting
Publication summary